2025, Volume 18, Issue 9, pp 909 – 913

Cerebrolysin treatment in a case of post-herpes simplex encephalitis with neuropsychiatric symptoms

Issues

Special Issues

Authors and Affiliations

* Corresponding author Soo Hwan Yim, Department of Neurology, Gangneung Asan Hospital, College of Medicine, Ulsan University, Gangneung, Republic of Korea; E-mail: yimsh3687@gmail.com

Abstract

Herpes simplex encephalitis (HSE) is a severe central nervous system (CNS) infection associated with cognitive decline, psychotic symptoms, and epilepsy. Despite aggressive antiviral and corticosteroid treatments, post-HSE complications remain challenging to manage. We report a case of a 33-year-old female patient with post-HSE neuropsychiatric symptoms who showed significant improvement following Cerebrolysin treatment. The patient was treated with acyclovir and dexamethasone in the acute phase, followed by Cerebrolysin administration in the post-acute phase. This case highlights the potential therapeutic role of Cerebrolysin in managing post-encephalitic cognitive dysfunction, underscoring the need for further studies.

Keywords

About this article

PMC ID: PMC12577782
PubMed ID: 41178897
DOI: 10.25122/jml-2025-0052

Article Publishing Date (print):
Available Online: 

Journal information

ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life

Copyright License: Open Access

This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.

Issues

Special Issues